Global Pediatric Gastrointestinal Drugs Supply, Demand and Key Producers, 2023-2029

Page: 124

Published Date: 19 Mar 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Pediatric Gastrointestinal Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Pediatric Gastrointestinal Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Pediatric Gastrointestinal Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pediatric Gastrointestinal Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Pediatric Gastrointestinal Drugs total market, 2018-2029, (USD Million)
Global Pediatric Gastrointestinal Drugs total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Pediatric Gastrointestinal Drugs total market, key domestic companies and share, (USD Million)
Global Pediatric Gastrointestinal Drugs revenue by player and market share 2018-2023, (USD Million)
Global Pediatric Gastrointestinal Drugs total market by Type, CAGR, 2018-2029, (USD Million)
Global Pediatric Gastrointestinal Drugs total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Pediatric Gastrointestinal Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Sanofi, Aptalis, Eisai, Pfizer, Zeria (Tillotts), GlaxoSmithKline, Salix Pharmaceuticals and Perrigo, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pediatric Gastrointestinal Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Pediatric Gastrointestinal Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Pediatric Gastrointestinal Drugs Market, Segmentation by Type
    Tablets
    Pills
    Oral Liquid

Global Pediatric Gastrointestinal Drugs Market, Segmentation by Application
    Hospital Pharmacies
    Online Pharmacies
    Retail Pharmacies

Companies Profiled:
    AstraZeneca
    Sanofi
    Aptalis
    Eisai
    Pfizer
    Zeria (Tillotts)
    GlaxoSmithKline
    Salix Pharmaceuticals
    Perrigo
    Abbott
    Honz Pharmaceutical
    Shandong DYNE Marine Biopharmaceutical
    Sunflower Pharmaceutical
    Jiangzhong Pharmaceutical
    Yabao Pharmaceutical
    Jumpcan Pharmaceutical
    Hansen Pharmaceutical

Key Questions Answered
1. How big is the global Pediatric Gastrointestinal Drugs market?
2. What is the demand of the global Pediatric Gastrointestinal Drugs market?
3. What is the year over year growth of the global Pediatric Gastrointestinal Drugs market?
4. What is the total value of the global Pediatric Gastrointestinal Drugs market?
5. Who are the major players in the global Pediatric Gastrointestinal Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Pediatric Gastrointestinal Drugs Introduction
    1.2 World Pediatric Gastrointestinal Drugs Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Pediatric Gastrointestinal Drugs Total Market by Region (by Headquarter Location)
        1.3.1 World Pediatric Gastrointestinal Drugs Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Pediatric Gastrointestinal Drugs Market Size (2018-2029)
        1.3.3 China Pediatric Gastrointestinal Drugs Market Size (2018-2029)
        1.3.4 Europe Pediatric Gastrointestinal Drugs Market Size (2018-2029)
        1.3.5 Japan Pediatric Gastrointestinal Drugs Market Size (2018-2029)
        1.3.6 South Korea Pediatric Gastrointestinal Drugs Market Size (2018-2029)
        1.3.7 ASEAN Pediatric Gastrointestinal Drugs Market Size (2018-2029)
        1.3.8 India Pediatric Gastrointestinal Drugs Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Pediatric Gastrointestinal Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Pediatric Gastrointestinal Drugs Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Pediatric Gastrointestinal Drugs Consumption Value (2018-2029)
    2.2 World Pediatric Gastrointestinal Drugs Consumption Value by Region
        2.2.1 World Pediatric Gastrointestinal Drugs Consumption Value by Region (2018-2023)
        2.2.2 World Pediatric Gastrointestinal Drugs Consumption Value Forecast by Region (2024-2029)
    2.3 United States Pediatric Gastrointestinal Drugs Consumption Value (2018-2029)
    2.4 China Pediatric Gastrointestinal Drugs Consumption Value (2018-2029)
    2.5 Europe Pediatric Gastrointestinal Drugs Consumption Value (2018-2029)
    2.6 Japan Pediatric Gastrointestinal Drugs Consumption Value (2018-2029)
    2.7 South Korea Pediatric Gastrointestinal Drugs Consumption Value (2018-2029)
    2.8 ASEAN Pediatric Gastrointestinal Drugs Consumption Value (2018-2029)
    2.9 India Pediatric Gastrointestinal Drugs Consumption Value (2018-2029)

3 World Pediatric Gastrointestinal Drugs Companies Competitive Analysis
    3.1 World Pediatric Gastrointestinal Drugs Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Pediatric Gastrointestinal Drugs Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Pediatric Gastrointestinal Drugs in 2022
        3.2.3 Global Concentration Ratios (CR8) for Pediatric Gastrointestinal Drugs in 2022
    3.3 Pediatric Gastrointestinal Drugs Company Evaluation Quadrant
    3.4 Pediatric Gastrointestinal Drugs Market: Overall Company Footprint Analysis
        3.4.1 Pediatric Gastrointestinal Drugs Market: Region Footprint
        3.4.2 Pediatric Gastrointestinal Drugs Market: Company Product Type Footprint
        3.4.3 Pediatric Gastrointestinal Drugs Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Pediatric Gastrointestinal Drugs Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Pediatric Gastrointestinal Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Pediatric Gastrointestinal Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Pediatric Gastrointestinal Drugs Consumption Value Comparison
        4.2.1 United States VS China: Pediatric Gastrointestinal Drugs Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Pediatric Gastrointestinal Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Pediatric Gastrointestinal Drugs Companies and Market Share, 2018-2023
        4.3.1 United States Based Pediatric Gastrointestinal Drugs Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Pediatric Gastrointestinal Drugs Revenue, (2018-2023)
    4.4 China Based Companies Pediatric Gastrointestinal Drugs Revenue and Market Share, 2018-2023
        4.4.1 China Based Pediatric Gastrointestinal Drugs Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Pediatric Gastrointestinal Drugs Revenue, (2018-2023)
    4.5 Rest of World Based Pediatric Gastrointestinal Drugs Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Pediatric Gastrointestinal Drugs Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Pediatric Gastrointestinal Drugs Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Pediatric Gastrointestinal Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Tablets
        5.2.2 Pills
        5.2.3 Oral Liquid
    5.3 Market Segment by Type
        5.3.1 World Pediatric Gastrointestinal Drugs Market Size by Type (2018-2023)
        5.3.2 World Pediatric Gastrointestinal Drugs Market Size by Type (2024-2029)
        5.3.3 World Pediatric Gastrointestinal Drugs Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Pediatric Gastrointestinal Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital Pharmacies
        6.2.2 Online Pharmacies
        6.2.3 Retail Pharmacies
    6.3 Market Segment by Application
        6.3.1 World Pediatric Gastrointestinal Drugs Market Size by Application (2018-2023)
        6.3.2 World Pediatric Gastrointestinal Drugs Market Size by Application (2024-2029)
        6.3.3 World Pediatric Gastrointestinal Drugs Market Size by Application (2018-2029)

7 Company Profiles
    7.1 AstraZeneca
        7.1.1 AstraZeneca Details
        7.1.2 AstraZeneca Major Business
        7.1.3 AstraZeneca Pediatric Gastrointestinal Drugs Product and Services
        7.1.4 AstraZeneca Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 AstraZeneca Recent Developments/Updates
        7.1.6 AstraZeneca Competitive Strengths & Weaknesses
    7.2 Sanofi
        7.2.1 Sanofi Details
        7.2.2 Sanofi Major Business
        7.2.3 Sanofi Pediatric Gastrointestinal Drugs Product and Services
        7.2.4 Sanofi Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Sanofi Recent Developments/Updates
        7.2.6 Sanofi Competitive Strengths & Weaknesses
    7.3 Aptalis
        7.3.1 Aptalis Details
        7.3.2 Aptalis Major Business
        7.3.3 Aptalis Pediatric Gastrointestinal Drugs Product and Services
        7.3.4 Aptalis Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Aptalis Recent Developments/Updates
        7.3.6 Aptalis Competitive Strengths & Weaknesses
    7.4 Eisai
        7.4.1 Eisai Details
        7.4.2 Eisai Major Business
        7.4.3 Eisai Pediatric Gastrointestinal Drugs Product and Services
        7.4.4 Eisai Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Eisai Recent Developments/Updates
        7.4.6 Eisai Competitive Strengths & Weaknesses
    7.5 Pfizer
        7.5.1 Pfizer Details
        7.5.2 Pfizer Major Business
        7.5.3 Pfizer Pediatric Gastrointestinal Drugs Product and Services
        7.5.4 Pfizer Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Pfizer Recent Developments/Updates
        7.5.6 Pfizer Competitive Strengths & Weaknesses
    7.6 Zeria (Tillotts)
        7.6.1 Zeria (Tillotts) Details
        7.6.2 Zeria (Tillotts) Major Business
        7.6.3 Zeria (Tillotts) Pediatric Gastrointestinal Drugs Product and Services
        7.6.4 Zeria (Tillotts) Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Zeria (Tillotts) Recent Developments/Updates
        7.6.6 Zeria (Tillotts) Competitive Strengths & Weaknesses
    7.7 GlaxoSmithKline
        7.7.1 GlaxoSmithKline Details
        7.7.2 GlaxoSmithKline Major Business
        7.7.3 GlaxoSmithKline Pediatric Gastrointestinal Drugs Product and Services
        7.7.4 GlaxoSmithKline Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 GlaxoSmithKline Recent Developments/Updates
        7.7.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.8 Salix Pharmaceuticals
        7.8.1 Salix Pharmaceuticals Details
        7.8.2 Salix Pharmaceuticals Major Business
        7.8.3 Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Product and Services
        7.8.4 Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Salix Pharmaceuticals Recent Developments/Updates
        7.8.6 Salix Pharmaceuticals Competitive Strengths & Weaknesses
    7.9 Perrigo
        7.9.1 Perrigo Details
        7.9.2 Perrigo Major Business
        7.9.3 Perrigo Pediatric Gastrointestinal Drugs Product and Services
        7.9.4 Perrigo Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Perrigo Recent Developments/Updates
        7.9.6 Perrigo Competitive Strengths & Weaknesses
    7.10 Abbott
        7.10.1 Abbott Details
        7.10.2 Abbott Major Business
        7.10.3 Abbott Pediatric Gastrointestinal Drugs Product and Services
        7.10.4 Abbott Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Abbott Recent Developments/Updates
        7.10.6 Abbott Competitive Strengths & Weaknesses
    7.11 Honz Pharmaceutical
        7.11.1 Honz Pharmaceutical Details
        7.11.2 Honz Pharmaceutical Major Business
        7.11.3 Honz Pharmaceutical Pediatric Gastrointestinal Drugs Product and Services
        7.11.4 Honz Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Honz Pharmaceutical Recent Developments/Updates
        7.11.6 Honz Pharmaceutical Competitive Strengths & Weaknesses
    7.12 Shandong DYNE Marine Biopharmaceutical
        7.12.1 Shandong DYNE Marine Biopharmaceutical Details
        7.12.2 Shandong DYNE Marine Biopharmaceutical Major Business
        7.12.3 Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Product and Services
        7.12.4 Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Shandong DYNE Marine Biopharmaceutical Recent Developments/Updates
        7.12.6 Shandong DYNE Marine Biopharmaceutical Competitive Strengths & Weaknesses
    7.13 Sunflower Pharmaceutical
        7.13.1 Sunflower Pharmaceutical Details
        7.13.2 Sunflower Pharmaceutical Major Business
        7.13.3 Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Product and Services
        7.13.4 Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Sunflower Pharmaceutical Recent Developments/Updates
        7.13.6 Sunflower Pharmaceutical Competitive Strengths & Weaknesses
    7.14 Jiangzhong Pharmaceutical
        7.14.1 Jiangzhong Pharmaceutical Details
        7.14.2 Jiangzhong Pharmaceutical Major Business
        7.14.3 Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Product and Services
        7.14.4 Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Jiangzhong Pharmaceutical Recent Developments/Updates
        7.14.6 Jiangzhong Pharmaceutical Competitive Strengths & Weaknesses
    7.15 Yabao Pharmaceutical
        7.15.1 Yabao Pharmaceutical Details
        7.15.2 Yabao Pharmaceutical Major Business
        7.15.3 Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Product and Services
        7.15.4 Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Yabao Pharmaceutical Recent Developments/Updates
        7.15.6 Yabao Pharmaceutical Competitive Strengths & Weaknesses
    7.16 Jumpcan Pharmaceutical
        7.16.1 Jumpcan Pharmaceutical Details
        7.16.2 Jumpcan Pharmaceutical Major Business
        7.16.3 Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Product and Services
        7.16.4 Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 Jumpcan Pharmaceutical Recent Developments/Updates
        7.16.6 Jumpcan Pharmaceutical Competitive Strengths & Weaknesses
    7.17 Hansen Pharmaceutical
        7.17.1 Hansen Pharmaceutical Details
        7.17.2 Hansen Pharmaceutical Major Business
        7.17.3 Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Product and Services
        7.17.4 Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.17.5 Hansen Pharmaceutical Recent Developments/Updates
        7.17.6 Hansen Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Pediatric Gastrointestinal Drugs Industry Chain
    8.2 Pediatric Gastrointestinal Drugs Upstream Analysis
    8.3 Pediatric Gastrointestinal Drugs Midstream Analysis
    8.4 Pediatric Gastrointestinal Drugs Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Pediatric Gastrointestinal Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Pediatric Gastrointestinal Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Pediatric Gastrointestinal Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Pediatric Gastrointestinal Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Pediatric Gastrointestinal Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Pediatric Gastrointestinal Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Pediatric Gastrointestinal Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Pediatric Gastrointestinal Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Pediatric Gastrointestinal Drugs Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Pediatric Gastrointestinal Drugs Players in 2022
    Table 12. World Pediatric Gastrointestinal Drugs Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Pediatric Gastrointestinal Drugs Company Evaluation Quadrant
    Table 14. Head Office of Key Pediatric Gastrointestinal Drugs Player
    Table 15. Pediatric Gastrointestinal Drugs Market: Company Product Type Footprint
    Table 16. Pediatric Gastrointestinal Drugs Market: Company Product Application Footprint
    Table 17. Pediatric Gastrointestinal Drugs Mergers & Acquisitions Activity
    Table 18. United States VS China Pediatric Gastrointestinal Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Pediatric Gastrointestinal Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Pediatric Gastrointestinal Drugs Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Pediatric Gastrointestinal Drugs Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Pediatric Gastrointestinal Drugs Revenue Market Share (2018-2023)
    Table 23. China Based Pediatric Gastrointestinal Drugs Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Pediatric Gastrointestinal Drugs Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Pediatric Gastrointestinal Drugs Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Pediatric Gastrointestinal Drugs Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Pediatric Gastrointestinal Drugs Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Pediatric Gastrointestinal Drugs Revenue Market Share (2018-2023)
    Table 29. World Pediatric Gastrointestinal Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Pediatric Gastrointestinal Drugs Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Pediatric Gastrointestinal Drugs Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Pediatric Gastrointestinal Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Pediatric Gastrointestinal Drugs Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Pediatric Gastrointestinal Drugs Market Size by Application (2024-2029) & (USD Million)
    Table 35. AstraZeneca Basic Information, Area Served and Competitors
    Table 36. AstraZeneca Major Business
    Table 37. AstraZeneca Pediatric Gastrointestinal Drugs Product and Services
    Table 38. AstraZeneca Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. AstraZeneca Recent Developments/Updates
    Table 40. AstraZeneca Competitive Strengths & Weaknesses
    Table 41. Sanofi Basic Information, Area Served and Competitors
    Table 42. Sanofi Major Business
    Table 43. Sanofi Pediatric Gastrointestinal Drugs Product and Services
    Table 44. Sanofi Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Sanofi Recent Developments/Updates
    Table 46. Sanofi Competitive Strengths & Weaknesses
    Table 47. Aptalis Basic Information, Area Served and Competitors
    Table 48. Aptalis Major Business
    Table 49. Aptalis Pediatric Gastrointestinal Drugs Product and Services
    Table 50. Aptalis Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Aptalis Recent Developments/Updates
    Table 52. Aptalis Competitive Strengths & Weaknesses
    Table 53. Eisai Basic Information, Area Served and Competitors
    Table 54. Eisai Major Business
    Table 55. Eisai Pediatric Gastrointestinal Drugs Product and Services
    Table 56. Eisai Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Eisai Recent Developments/Updates
    Table 58. Eisai Competitive Strengths & Weaknesses
    Table 59. Pfizer Basic Information, Area Served and Competitors
    Table 60. Pfizer Major Business
    Table 61. Pfizer Pediatric Gastrointestinal Drugs Product and Services
    Table 62. Pfizer Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Pfizer Recent Developments/Updates
    Table 64. Pfizer Competitive Strengths & Weaknesses
    Table 65. Zeria (Tillotts) Basic Information, Area Served and Competitors
    Table 66. Zeria (Tillotts) Major Business
    Table 67. Zeria (Tillotts) Pediatric Gastrointestinal Drugs Product and Services
    Table 68. Zeria (Tillotts) Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Zeria (Tillotts) Recent Developments/Updates
    Table 70. Zeria (Tillotts) Competitive Strengths & Weaknesses
    Table 71. GlaxoSmithKline Basic Information, Area Served and Competitors
    Table 72. GlaxoSmithKline Major Business
    Table 73. GlaxoSmithKline Pediatric Gastrointestinal Drugs Product and Services
    Table 74. GlaxoSmithKline Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. GlaxoSmithKline Recent Developments/Updates
    Table 76. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 77. Salix Pharmaceuticals Basic Information, Area Served and Competitors
    Table 78. Salix Pharmaceuticals Major Business
    Table 79. Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Product and Services
    Table 80. Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Salix Pharmaceuticals Recent Developments/Updates
    Table 82. Salix Pharmaceuticals Competitive Strengths & Weaknesses
    Table 83. Perrigo Basic Information, Area Served and Competitors
    Table 84. Perrigo Major Business
    Table 85. Perrigo Pediatric Gastrointestinal Drugs Product and Services
    Table 86. Perrigo Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Perrigo Recent Developments/Updates
    Table 88. Perrigo Competitive Strengths & Weaknesses
    Table 89. Abbott Basic Information, Area Served and Competitors
    Table 90. Abbott Major Business
    Table 91. Abbott Pediatric Gastrointestinal Drugs Product and Services
    Table 92. Abbott Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Abbott Recent Developments/Updates
    Table 94. Abbott Competitive Strengths & Weaknesses
    Table 95. Honz Pharmaceutical Basic Information, Area Served and Competitors
    Table 96. Honz Pharmaceutical Major Business
    Table 97. Honz Pharmaceutical Pediatric Gastrointestinal Drugs Product and Services
    Table 98. Honz Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Honz Pharmaceutical Recent Developments/Updates
    Table 100. Honz Pharmaceutical Competitive Strengths & Weaknesses
    Table 101. Shandong DYNE Marine Biopharmaceutical Basic Information, Area Served and Competitors
    Table 102. Shandong DYNE Marine Biopharmaceutical Major Business
    Table 103. Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Product and Services
    Table 104. Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Shandong DYNE Marine Biopharmaceutical Recent Developments/Updates
    Table 106. Shandong DYNE Marine Biopharmaceutical Competitive Strengths & Weaknesses
    Table 107. Sunflower Pharmaceutical Basic Information, Area Served and Competitors
    Table 108. Sunflower Pharmaceutical Major Business
    Table 109. Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Product and Services
    Table 110. Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Sunflower Pharmaceutical Recent Developments/Updates
    Table 112. Sunflower Pharmaceutical Competitive Strengths & Weaknesses
    Table 113. Jiangzhong Pharmaceutical Basic Information, Area Served and Competitors
    Table 114. Jiangzhong Pharmaceutical Major Business
    Table 115. Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Product and Services
    Table 116. Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Jiangzhong Pharmaceutical Recent Developments/Updates
    Table 118. Jiangzhong Pharmaceutical Competitive Strengths & Weaknesses
    Table 119. Yabao Pharmaceutical Basic Information, Area Served and Competitors
    Table 120. Yabao Pharmaceutical Major Business
    Table 121. Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Product and Services
    Table 122. Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. Yabao Pharmaceutical Recent Developments/Updates
    Table 124. Yabao Pharmaceutical Competitive Strengths & Weaknesses
    Table 125. Jumpcan Pharmaceutical Basic Information, Area Served and Competitors
    Table 126. Jumpcan Pharmaceutical Major Business
    Table 127. Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Product and Services
    Table 128. Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 129. Jumpcan Pharmaceutical Recent Developments/Updates
    Table 130. Hansen Pharmaceutical Basic Information, Area Served and Competitors
    Table 131. Hansen Pharmaceutical Major Business
    Table 132. Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Product and Services
    Table 133. Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 134. Global Key Players of Pediatric Gastrointestinal Drugs Upstream (Raw Materials)
    Table 135. Pediatric Gastrointestinal Drugs Typical Customers
List of Figure
    Figure 1. Pediatric Gastrointestinal Drugs Picture
    Figure 2. World Pediatric Gastrointestinal Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Pediatric Gastrointestinal Drugs Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Pediatric Gastrointestinal Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Pediatric Gastrointestinal Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Pediatric Gastrointestinal Drugs Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Pediatric Gastrointestinal Drugs Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Pediatric Gastrointestinal Drugs Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Pediatric Gastrointestinal Drugs Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Pediatric Gastrointestinal Drugs Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Pediatric Gastrointestinal Drugs Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Pediatric Gastrointestinal Drugs Revenue (2018-2029) & (USD Million)
    Figure 13. Pediatric Gastrointestinal Drugs Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Pediatric Gastrointestinal Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Pediatric Gastrointestinal Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Pediatric Gastrointestinal Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Pediatric Gastrointestinal Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Pediatric Gastrointestinal Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Pediatric Gastrointestinal Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Pediatric Gastrointestinal Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Pediatric Gastrointestinal Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Pediatric Gastrointestinal Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Pediatric Gastrointestinal Drugs by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Pediatric Gastrointestinal Drugs Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Pediatric Gastrointestinal Drugs Markets in 2022
    Figure 27. United States VS China: Pediatric Gastrointestinal Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Pediatric Gastrointestinal Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Pediatric Gastrointestinal Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Pediatric Gastrointestinal Drugs Market Size Market Share by Type in 2022
    Figure 31. Tablets
    Figure 32. Pills
    Figure 33. Oral Liquid
    Figure 34. World Pediatric Gastrointestinal Drugs Market Size Market Share by Type (2018-2029)
    Figure 35. World Pediatric Gastrointestinal Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World Pediatric Gastrointestinal Drugs Market Size Market Share by Application in 2022
    Figure 37. Hospital Pharmacies
    Figure 38. Online Pharmacies
    Figure 39. Retail Pharmacies
    Figure 40. Pediatric Gastrointestinal Drugs Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Pediatric Gastrointestinal Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Pediatric Gastrointestinal Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 10 Feb 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Pediatric Gastrointestinal Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Pediatric Gastrointestinal Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Pediatric Gastrointestinal Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 20 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Pediatric Gastrointestinal Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Pediatric Gastrointestinal Drugs

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>